跳至主要内容
临床试验/ACTRN12609000006246
ACTRN12609000006246已完成4 期

An evaluation of the safety and effectiveness of patient-controlled intranasal fentanyl for relieving pain in birthing women.

Western Health0 个研究点目标入组 50 人开始时间: 2009年1月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 18 years old and over;
  • Singleton pregnancy;
  • Term – at least 37 weeks;
  • Prima Gravida.

排除标准

  • Failure to provide consent;
  • Complicated pregnancy – i.e. – no pregnancy induced hypertension, pre-eclampsia, gestational diabetes mellitus;
  • Abnormal foetal positioning i.e. breech;
  • Placental abnormalities;
  • Non-singleton pregnancy;
  • Allergy to opioid analgesia;
  • Bronchial asthma
  • Myasthenia gravis;
  • Opioid Tolerance including regular use of methadone, buprenorphine, heroin, morphine, oxycodone;
  • Chronic nasal problems i.e. hay-fever, sinusitis, common cold;
  • Inability to self administer Patient-Controlled Intranasal Fentanyl (PCIF).

研究者

相似试验